Multiple dose netivudine, a potent anti-varicella zoster virus agent, in healthy elderly volunteers and patients with shingles

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 3, 1996, Pages 583-597

  Peck, R W ^a   Crome, P ^b   Wood, M J ^c   McKendrick, M W ^d   Bannister, B ^e   Mandal, B K ^f   Crooks, R J ^a  

^a WELLCOME RESEARCH LABORATORIES   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

^c BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^d ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^e Department of Infectious and Tropical Diseases   (United Kingdom)

^f NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 PROPYNYLURACIL; ANTIVIRUS AGENT; DRUG METABOLITE; NETIVUDINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; FATIGUE; FEMALE; FOOD INTAKE; HEADACHE; HERPES ZOSTER; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; ARABINOFURANOSYLURACIL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE;

EID: 9244258584     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.3.583     Document Type: Article

References (14)

1. Buick, A. R. & Sheung, C. T. C. (1993). Determination of 1-(β-D-arabinofuranosyl)-5-(1-propynyl)uracil, and a metabolite, 5-propynyluracil, in plasma using ASTED (automated sequential trace enrichment of dialysates) combined, on-line with high performance liquid chromatography. Journal of Chromatography 617, 65-70.
2. Cockroft, D. W. & Gault, M. H. (1976). Prediction of creatinine clearance from serum creatinine. Nephron 16, 31-41.
3. Cooper, J. D. H., Sheung, C. T. C. & Buick, A. R. (1994). Automated sequential trace enrichment of dialysates combined with high-performance liquid chromatography and automated heart-cutting for the determination of the nucleoside 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)uracil and its metabolite 5-propynyluracil in urine. Journal of Chromatography 652, 15-21.
4. Crooks, R. J., Fiddian, A. P. & Jones, D. A. (1991). Zoster-associated chronic pain: an overview of clinical trials with acyclovir. Scandinavian Journal of Infectious Diseases 78, 62-8.
5. Fiddian, A. P. & the International Zoster Study Group. (1995). A randomised controlled trial of Zovirax (acyclovir, ACV) versus netivudine for the treatment of herpes zoster. Antiviral Research 26/3, A297.
6. Gracely, R. H., Dubner, R. & McGrath, P. A. (1982). Fentanyl reduces the intensity of painful tooth pulp sensation: controlling for detection of active drugs. Anaesthesia and Analgesia 61, 751-5.
7. Gracely, R. H., Dubner, R. & McGrath, P. A. (1979). Narcotic analgesia: fentanyl reduces the intensity but not the unpleasantness of painful tooth pulp sensations. Science 203, 1261-3.
8. Huff, J. C., Bean, B., Balfour, H. H., Laskin, O. L., Connor, J. D., Corey, L. et al. (1988). Therapy of herpes zoster with oral acyclovir. American Journal of Medicine 85, Suppl. 2A, 84-9.
9. Peck, R. W., Weatherley, B. C., Wootton, R., Crome, P., Holdich, T. A. & Posner, J. (1995a). Pharmacokinetics and tolerability of single doses of 882C87, a potent, new anti-varicellazoster virus agent, in healthy volunteers. Antimicrobial Agents and Chemotherapy 39, 20-7.
10. Peck, R. W., Wootton, R., Lee, D. R., Jackson, S. H. D. & Posner, J. (1995b). The bioavailability and disposition of 1-(β-D-arabinofuranosyl)-5-(1-propynyl)uracil (882C87), a potent, new anti-varicella zoster virus agent. British Journal of Clinical Pharmacology 39, 143-9.
11. Rahim, S. G., Trivedi, N., Selway, J., Darby, G., Collins, P., Powell, K. P. et al. (1992). 5-Alkynyl pyrimidine nucleosides as potent selective inhibitors of varicella-zoster virus. Antiviral Chemistry and Chemotherapy 3, 293-7.
12. Rowland, M. & Tozer, T. N. (1989). Clinical Pharmacokinetics: Concepts and Applications, 2nd edn. Lea & Feabiger, Philadelphia.
13. Wood, M. J., McKendrick, M. W., Bannister, B., Mandal, B. K., Peck, R. W. & Crooks, R. J. (1993). Preliminary pharmacokinetics and safety of 882C87 in patients with herpes zoster. Journal of Medical Virology, Suppl. 1, 154-7.
14. Wood, M. J., Ogan, P. H., McKendrick, M. W., Care, C. D., McGill, J. I. & Webb, E. M. (1988). Efficacy of oral acyclovir treatment of acute herpes zoster. American Journal of Medicine 85, Suppl. 2A, 79-83.